Search

everythinglearnresearchcommunity

for

Search:↓

Scientists successfully purified a protein called Wnt3a, which is involved in processes like hair growth, but the overall yield was low, suggesting more work is needed to improve this.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Combining PRP with other treatments can improve hair loss outcomes.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

Povidone-iodine nail solution effectively treats nail infections caused by chemotherapy.

Angio PRP speeds up skin wound healing and reduces inflammation.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

ICAM-1 helps regulate hair growth cycles and skin remodeling.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Certain SPINK5 gene mutations are common in Israeli families with Comèl-Netherton syndrome.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Ixekizumab effectively treats generalized pustular psoriasis.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Ulcerative colitis involves immune activation, chronic inflammation, and metabolic issues, some of which persist even during remission.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Hydrophilic carbon dots cause one protein to clump more and prevent another from clumping.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

The combined treatment improved scalp health in women with early-stage hair loss.

A rare case showed alopecia areata and lichen planus occurring together in one person.

The research found that the properties of solid-state Electronic Circular Dichroism (ss-ECD) are influenced by the orientation of local crystals, which could help in examining and mapping chiral materials like pharmaceutical ingredients.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Four antibodies were developed to help study hair follicle cell differentiation.

PRP therapy and minoxidil combo works best for male hair loss.

Scalp cooling significantly reduces chemotherapy-induced hair loss.